{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T17:12:47Z","timestamp":1785777167668,"version":"3.56.0"},"reference-count":53,"publisher":"Elsevier","isbn-type":[{"value":"9780323994002","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.ircmb.2022.04.016","type":"book-chapter","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T14:50:54Z","timestamp":1657291854000},"page":"97-116","source":"Crossref","is-referenced-by-count":5,"title":["Immune response and locoregional treatments for peritoneal carcinomatosis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8031-7846","authenticated-orcid":false,"given":"Caterina","family":"Fiorentini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8525-084X","authenticated-orcid":false,"given":"Donatella","family":"Sarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9346-1409","authenticated-orcid":false,"given":"Stefano","family":"Guadagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5615-889X","authenticated-orcid":false,"given":"Giammaria","family":"Fiorentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.ircmb.2022.04.016_bb0010","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"38323","author":"Andr\u00e9","year":"2020","journal-title":"New Eng. J. Med."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0015","series-title":"Peritoneal Cancer","author":"Anwar","year":"2022"},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0020","article-title":"Peritoneal metastases from breast cancer: a scoping review","volume":"118","author":"Beniey","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0025","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/jnci\/djab001","article-title":"Site of recurrence and survival after surgery for colorectal peritoneal metastasis","volume":"1138","author":"Breuer","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/path.4942","article-title":"The peritoneum: healing, immunity, and diseases","volume":"2432","author":"Capobianco","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41467-020-20429-0","article-title":"Predicting postoperative peritoneal metastasis in gastric cancer with serosal invasion using a collagen nomogram","volume":"121","author":"Chen","year":"2021","journal-title":"Nat. Commun."},{"issue":"41","key":"10.1016\/bs.ircmb.2022.04.016_bb0040","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.3748\/wjg.v19.i41.6979","article-title":"Peritoneal carcinomatosis","volume":"19","author":"Coccolini","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/bs.ircmb.2022.04.016_bb0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1515\/pp-2017-0010","article-title":"Pharmacological principles of intraperitoneal and bidirectional chemotherapy","volume":"2","author":"de Bree","year":"2017","journal-title":"Pleura Perit."},{"issue":"5","key":"10.1016\/bs.ircmb.2022.04.016_bb0050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/biomedicines8050102","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with oxaliplatin, cisplatin, and doxorubicin in patients with peritoneal carcinomatosis: an open-label, single-arm, Phase II Clinical Trial","volume":"8","author":"De Simone","year":"2020","journal-title":"Biomedicines"},{"issue":"79","key":"10.1016\/bs.ircmb.2022.04.016_bb0055","first-page":"1","article-title":"The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer","volume":"1990","author":"Desiderio","year":"2017","journal-title":"Eur. J. Cancer Oxford Eng."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5306\/wjco.v11.i6.397","article-title":"Immune response activation following hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a pilot study","volume":"116","author":"Fiorentini","year":"2020","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jamcollsurg.2016.03.003","article-title":"Prognostic utility of immunoprofiling in colon cancer: results from a prospective, multicenter nodal ultrastaging trial","volume":"2231","author":"Flaherty","year":"2016","journal-title":"J. Am. College Surg."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0070","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1245\/s10434-020-08870-3","article-title":"Cellular immunoprofile of peritoneal environment during a HIPEC procedure","volume":"2713","author":"Franko","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0075","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1245\/s10434-017-5814-6","article-title":"Novel treatment with intraperitoneal MOC31PE immunotoxin in colorectal peritoneal metastasis: results from the ImmunoPeCa phase 1 trial","volume":"247","author":"Fr\u00f8ysnes","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0080","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11605-020-04886-y","article-title":"Prognostic impact and utility of immunoprofiling in the selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery CRS and heated intraperitoneal chemotherapy HIPEC","volume":"251","author":"Garland-Kledzik","year":"2021","journal-title":"J. Gastrointest. Surg. Off. J. Soc. Surg. Alim. Tract"},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0085","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1471-2407-14-148","article-title":"Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using cetuximab","volume":"14","author":"Go\u00e9r\u00e9","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0090","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/bjs5.50179","article-title":"Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy","volume":"35","author":"Hallam","year":"2019","journal-title":"BJS Open"},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0095","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ijc.21165","article-title":"Immunotherapy of malignant ascites with trifunctional antibodies","volume":"1173","author":"Heiss","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0100","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/ijc.25423","article-title":"The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II\/III trial","volume":"1279","author":"Heiss","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0105","first-page":"CD005340","article-title":"Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer","volume":"20161","author":"Jaaback","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0110","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/jcp.54.9.669","article-title":"Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer","volume":"549","author":"J\u00e4ger","year":"2001","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.semcdb.2018.09.007","article-title":"Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature","volume":"92","author":"Kastelein","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0120","series-title":"Management of Drainage for Malignant Ascites in Gynaecological Cancer. The Cochrane Database of Systematic Reviews","volume":"vol. 1212","author":"Kietpeerakool","year":"2019"},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0125","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41416-018-0150-6","article-title":"Randomised phase II trial to investigate catumaxomab (anti-EpCAM\u00d7anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer","volume":"1193","author":"Kn\u00f6dler","year":"2018","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jso.21051","article-title":"Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy","volume":"984","author":"Kusamura","year":"2008","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0135","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.3748\/wjg.v22.i34.7692","article-title":"Pathophysiology of colorectal peritoneal carcinomatosis: role of the peritoneum","volume":"2234","author":"Lemoine","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0140","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejso.2016.09.015","article-title":"Oxaliplatin versus mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis","volume":"431","author":"Leung","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0145","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1007\/s13277-016-4887-3","article-title":"Milky spots: omental functional units and hotbeds for peritoneal cancer metastasis","volume":"375","author":"Liu","year":"2016","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0150","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdz135","article-title":"Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study","volume":"307","author":"Matulonis","year":"2019","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0155","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41573-019-0025-4","article-title":"Therapeutic targeting of trained immunity","volume":"187","author":"Mulder","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"152","key":"10.1016\/bs.ircmb.2022.04.016_bb0160","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1021\/acsnano.0c10276","article-title":"Tumor-selective immune-active mild hyperthermia associated with chemotherapy in colon peritoneal metastasis by photoactivation of fluorouracil-gold nanoparticle complexes","volume":"23","author":"Mulens-Arias","year":"2021","journal-title":"ACS Nano."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/cancers12010034","article-title":"Overcoming drug resistance by taking advantage of physical principles: pressurized intraperitoneal aerosol chemotherapy PIPAC","volume":"121","author":"Nadiradze","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0170","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.asjsur.2021.09.028","article-title":"Effect of operation-introducing hyperthermic intraperitoneal chemotherapy on cellular immune function in patients with adenocarcinoma of the esophagogastric junction","volume":"451","author":"Nie","year":"2022","journal-title":"Asian J. Surg."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0175","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s10120-015-0489-9","article-title":"The efficacy of adjuvant immunochemotherapy with OK-432 after curative resection of gastric cancer: an individual patient data meta-analysis of randomized controlled trials","volume":"192","author":"Oba","year":"2016","journal-title":"Gastric Cancer"},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0180","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ejso.2015.06.001","article-title":"Quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy PIPAC","volume":"4110","author":"Odendahl","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0185","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1158\/1078-0432.CCR-05-1293","article-title":"Antitumor effects of systemic and local immunization with a CTL-directed peptide in combination with a local injection of OK-432","volume":"124","author":"Ono","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0190","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/jso.23728","article-title":"The American society of peritoneal surface malignancies evaluation of HIPEC with mitomycin C versus oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery","volume":"1107","author":"Prada-Villaverde","year":"2014","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0195","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases PRODIGE 7: a multicentre, randomised, open-label, phase 3 trial","volume":"222","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0200","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00000658-198910000-00008","article-title":"Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients","volume":"2104","author":"Rosenberg","year":"1989","journal-title":"Ann. Surg."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0205","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/jnci\/85.8.622","article-title":"Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer","volume":"858","author":"Rosenberg","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0210","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/cancers14010060","article-title":"Peritoneal metastasis: current status and treatment options","volume":"141","author":"Roth","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0215","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1182\/blood.V98.8.2526","article-title":"Induction of a long-lasting antitumor immunity by a trifunctional bispecific antibody","volume":"988","author":"Ruf","year":"2001","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0220","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"882","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0225","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3892\/ol.2013.1468","article-title":"Lung cancer and peritoneal carcinomatosis","volume":"63","author":"Sereno","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0230","first-page":"18","article-title":"Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis","volume":"281","author":"Solass","year":"2009","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0235","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/onc.2009.356","article-title":"Immunogenic death of colon cancer cells treated with oxaliplatin","volume":"294","author":"Tesniere","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0240","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1245\/s10434-021-10022-0","article-title":"Increased local inflammatory response to MOC31PE immunotoxin after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"289","author":"Thorgersen","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0245","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1369\/0022155417742897","article-title":"Development of peritoneal carcinomatosis in epithelial ovarian cancer: a review","volume":"662","author":"van Baal","year":"2018","journal-title":"J. Histochem. Cytochem. Off. J. Histochem. Soc."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0250","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/PPO.0b013e3181a58d95","article-title":"Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancy","volume":"153","author":"Van der Speeten","year":"2009","journal-title":"Cancer J. Sudbury Mass."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0255","first-page":"1501","article-title":"Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapy","volume":"232B","author":"van Ruth","year":"2003","journal-title":"Anticancer Res."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0260","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.bjc.6602924","article-title":"Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers","volume":"941","author":"Went","year":"2006","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.795390","article-title":"Effect of HIPEC on peritoneal recurrence in peritoneal metastasis treated with cytoreductive surgery: a systematic review","volume":"11","author":"Yap","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/bs.ircmb.2022.04.016_bb0270","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/onc.2015.82","article-title":"Hyperthermic intraperitoneal chemotherapy leads to an anticancer immune response via exposure of cell surface heat shock protein 90","volume":"352","author":"Zunino","year":"2016","journal-title":"Oncogene"}],"container-title":["International Review of Cell and Molecular Biology","Cellular Immunity in the Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644822000612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644822000612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T13:36:12Z","timestamp":1682948172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1937644822000612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323994002"],"references-count":53,"URL":"https:\/\/doi.org\/10.1016\/bs.ircmb.2022.04.016","relation":{},"ISSN":["1937-6448"],"issn-type":[{"value":"1937-6448","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}